OraSure Technologies to Present at Canaccord|Genuity's Medical Technology & Diagnostics Forum

OraSure Technologies to Present at Canaccord|Genuity's Medical Technology &
Diagnostics Forum

BETHLEHEM, Pa., Nov. 7, 2013 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc.
(Nasdaq:OSUR) today announced that Ronald H. Spair, COO & CFO, will speak to
the investment community at Canaccord|Genuity's Medical Technology &
Diagnostics Forum in New York City. The conference will be simultaneously
webcast over the Internet.

Mr. Spair is scheduled to speak November 14, at approximately 11:00 am Eastern
Time (8:00 am Pacific Time). Interested investors can access the live webcast
of the presentation by going to OraSure Technologies' web site,
www.orasure.com, and clicking on the Investor Info link.A replay of the
webcast will be available on OraSure Technologies' web site for seven
days.Alternatively, you can access the live webcast of the presentation via
the following link http://wsw.com/webcast/canaccord12/.

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and
distribution of oral fluid diagnostic and collection devices and other
technologies designed to detect or diagnose critical medical conditions. Its
innovative products include rapid tests for the detection of antibodies to HIV
and HCV at the point of care and testing solutions for detecting various drugs
of abuse. In addition, the Company is a leading provider of oral fluid sample
collection, stabilization and preparation products for molecular diagnostic
applications. OraSure's portfolio of products is sold globally to various
clinical laboratories, hospitals, clinics, community-based organizations and
other public health organizations, research and academic institutions,
distributors, government agencies, physicians' offices, and commercial and
industrial entities. The Company's products enable healthcare providers to
deliver critical information to patients, empowering them to make decisions to
improve and protect their health.

For more information on the Company, please go to www.orasure.com.

CONTACT: Company contact:
        
         Ronald H. Spair
         Chief Financial Officer
         610-882-1820
         Investorinfo@orasure.com
         www.orasure.com

company logo
 
Press spacebar to pause and continue. Press esc to stop.